Trinity Biotech (TRIB) EPS (Diluted) (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) EPS (Diluted) (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Trinity Biotech | 113.44 Mn | 108.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -256.27% |
| Sep 30, 2024 | 29.57% |
| Jun 30, 2024 | -74.37% |
| Mar 31, 2024 | 39.71% |
| Dec 31, 2023 | 18.14% |
| Sep 30, 2023 | -12.24% |
| Jun 30, 2023 | 90.79% |
| Mar 31, 2023 | 42.37% |
| Dec 31, 2022 | -95.12% |
| Sep 30, 2022 | 7.84% |
| Jun 30, 2022 | 38.87% |
| Mar 31, 2022 | -871.44% |
| Dec 31, 2021 | -100.00% |
| Sep 30, 2021 | 40,502,781.06% |
| Jun 30, 2021 | -100.00% |
| Mar 31, 2021 | 11,189,887.81% |
| Dec 31, 2020 | -100.00% |
| Dec 31, 2018 | -100.00% |
| Sep 30, 2018 | 25,783,408.91% |
| Dec 31, 2017 | -100.00% |